Patents by Inventor Subhadip GHATAK

Subhadip GHATAK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ELECTRIC FIELD PRODUCTION FOR REMEDIATION OF MICROORGANISMS
    Publication number: 20240049816
    Abstract: This invention is directed to a multilayered fabric that comprises an electrode bearing surface that is electrically connected to a voltage source, wherein upon application of a charge, the electrode bearing will generating an electric field to neutralize pathogens and other microorganisms coming in contact with the material.
    Type: Application
    Filed: December 20, 2021
    Publication date: February 15, 2024
    Inventors: Chandan K. SEN, Sashwati ROY, Subhadip GHATAK, Brent TOTO
  • ELECTROCEUTICAL FABRIC FOR ERADICATING CORONAVIRUS
    Publication number: 20230346994
    Abstract: Compositions and methods are provided for preparing an article that comprises an electroceutical material that comprises a redox pair of alternating metals that generate an electric current or field when exposed to an aqueous solution. In one embodiment filtering equipment including facial masks are prepared comprising the electroceutical materials.
    Type: Application
    Filed: May 11, 2021
    Publication date: November 2, 2023
    Inventors: Chandan K. SEN, Sashwati ROY, Subhadip GHATAK, Savita KHANNA
  • METHODS TO RE-ENGAGE A FETAL WOUND HEALING PATHWAY FOR ADULT SKIN REPAIR
    Publication number: 20230348913
    Abstract: Compositions and methods are provided for promoting wound healing in a subject by administering a composition that enhances the expression of the protein nonselenocysteine-containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) in wound-edge tissues. In accordance with one embodiment such compositions are used in conjunction with known treatments for use on chronic wounds including in diabetic patients.
    Type: Application
    Filed: March 2, 2021
    Publication date: November 2, 2023
    Inventors: Chandan K. SEN, Subhadip GHATAK, Sashwati ROY
  • NEUROGENIC TISSUE NANOTRANSFECTION IN THE MANAGEMENT OF CUTANEOUS DIABETIC POLYNEUROPATHY
    Publication number: 20230201376
    Abstract: Compositions and methods are provided for reprogramming demal fibroblasts to exhibit neurogenic properties including increased cell expression of NGF and Nt3 in vivo. In accordance with one embodiment such compositions are used in conjunction with standard treatment for use in treating neuropathic pain and stabilizing or stimulating production of PGP9.5+ mature nerve fiber in a diabetic patient’s tissues.
    Type: Application
    Filed: April 29, 2021
    Publication date: June 29, 2023
    Inventors: Chandan K. SEN, Subhadip GHATAK, Sashwati ROY, Savita KHANNA
  • CELL-TARGETED NANOPARTICLES TO INHIBIT RNA CARGO
    Publication number: 20230120162
    Abstract: Compositions and methods are provided for modifying the contents of exosomes released by target cells. In one embodiment cell targeted nanoparticles are used to deliver interference RNAs to the target cells which alter the packaging of exosomes released by the target cells.
    Type: Application
    Filed: February 26, 2021
    Publication date: April 20, 2023
    Inventors: Chandan K. SEN, Subhadip GHATAK, Sashwati ROY
  • THERAPEUTIC DELIVERY OF LOCKED NUCLEIC ACID CONJUGATED ANTISENSE MIR-1
    Publication number: 20230092762
    Abstract: Compositions and methods are provided for promote wound healing in a subject by administering a miR-1 inhibitor to a wound on subject. In accordance with one embodiment such compositions are used in conjunction with known treatments for use on chronic wounds including in diabetic patients.
    Type: Application
    Filed: February 23, 2021
    Publication date: March 23, 2023
    Inventors: Chandan K. SEN, Subhadip GHATAK
  • Compositions and methods for reprogramming somatic cells into induced vasculogenic cells
    Patent number: 11578107
    Abstract: Disclosed herein are compositions and methods that involve using compositions containing one or more of ETV2, FOXC2, FLI1 and a miR-200b inhibitor for directly reprogramming somatic cells into induced vasculogenic cells both in vitro and in vivo. These compositions and methods are useful for a variety of purposes, including the development of pro-angiogenic therapies.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: February 14, 2023
    Assignee: Ohio State Innovation Foundation
    Inventors: Daniel Gallego-Perez, Ly James Lee, Durba Pal, Subhadip Ghatak, Chandan Sen
  • Compositions and methods for reprogramming somatic cells into induced vasculogenic cells
    Patent number: 11518790
    Abstract: Disclosed herein are compositions and methods that involve using compositions containing one or more of ETV2, FOXC2, FLI1 and a miR-200b inhibitor for directly reprogramming somatic cells into induced vasculogenic cells both in vitro and in vivo. These compositions and methods are useful for a variety of purposes, including the development of pro-angiogenic therapies.
    Type: Grant
    Filed: December 20, 2017
    Date of Patent: December 6, 2022
    Assignee: Ohio State Innovation Foundation
    Inventors: Daniel Gallego-Perez, Ly James Lee, Durba Pal, Subhadip Ghatak, Chandan Sen
  • NOVEL COMPOSITIONS FOR DISRUPTING BIOFILMS
    Publication number: 20220354932
    Abstract: Compositions and methods are provided for disrupting biofilms formed by microbial organisms. In accordance with one embodiment such compositions are used in conjunction with standard treatment for use on chronic wounds. In one embodiment the biofilm disrupting composition comprises a nuclease and aurine tricarboxylic acid. The biofilm disrupting compositions disclosed herein can be used in conjunction with a therapeutic pharmaceutical composition comprising standard antibiotics.
    Type: Application
    Filed: September 4, 2020
    Publication date: November 10, 2022
    Inventors: Chandan K. SEN, Subhadip GHATAK
  • VASCULOGENIC FIBROBLASTS
    Publication number: 20220333107
    Abstract: Compositions and methods are provided for reprogramming dermal fibroblasts to exhibit vasculogenic properties including the ability to stimulate vasculogenesis in vivo. In accordance with one embodiment such compositions are used in conjunction with standard treatment for use on chronic wounds including in diabetic patients.
    Type: Application
    Filed: September 18, 2020
    Publication date: October 20, 2022
    Inventors: Chandan K. SEN, Kanhaiya SINGH, Sashwati ROY, Mervin C. YODER, Saba TABASUM, Ahmed Safwat ABOU-HASHEM, Subhadip GHATAK
  • COMPOSITIONS AND METHODS FOR REPROGRAMMING SOMATIC CELLS INTO INDUCED VASCULOGENIC CELLS
    Publication number: 20200115425
    Abstract: Disclosed herein are compositions and methods for directly reprogramming somatic cells into induced vasculogenic cells both in vitro and in vivo. These compositions and methods are useful for a variety of purposes, including the development of pro-angiogenic therapies.
    Type: Application
    Filed: December 20, 2017
    Publication date: April 16, 2020
    Inventors: Daniel Gallego-Perez, Ly James Lee, Durba Pal, Subhadip Ghatak, Chandan Sen
  • TOPICAL TOCOTRIENOL COMPOSITIONS AND METHODS OF INCREASING SKIN STEM CELLS
    Publication number: 20190365705
    Abstract: The present disclosure relates to topical tocotrienol compositions, dosing regimens, and methods for increasing the stem cell content of the skin. The present invention further relates to topical tocotrienol compositions, dosing regimens, and methods for the treatment of skin disorders.
    Type: Application
    Filed: January 22, 2018
    Publication date: December 5, 2019
    Inventors: Chandan SEN, Savita KHANNA, Subhadip GHATAK